Inventurus Knowledge Solutions Ltd
IKS • Health Care
ROCE
29.09%
FY24 Actual
D/E Ratio
0.48
Leveraged
5Y Rev CAGR
37.0%
High Growth
Profit Margin
| Metrics (Values in Cr) | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|---|---|
| Total Revenue | 568.78 | 784.46(+37.9%) |
IKS • Health Care
ROCE
29.09%
FY24 Actual
D/E Ratio
0.48
Leveraged
5Y Rev CAGR
37.0%
High Growth
Profit Margin
| Metrics (Values in Cr) | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|---|---|
| Total Revenue | 568.78 | 784.46(+37.9%) |
25.1%
5Y Average
1,857.94(+75.3%) |
2,702.99(+45.5%) |
3,075.68 |
| Operating Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Operating Profit | — | — | — | — | — | — |
| Raw Profit | 0 | 0 | 0 | 0 | 0 | — |
| Operating Expenses | 18.21 | 50.98(+180.0%) | 82.35(+61.5%) | 136.53(+65.8%) | 202.63(+48.4%) | 2,046.61 |
| Selling General And Administrative Expenses | 34.66 | 59.84(+72.6%) | 92.86(+55.2%) | 192.52(+107.3%) | 187.58(-2.6%) | — |
| Depreciation And Amortization | 30.34 | 23.31(-23.2%) | 24.55(+5.3%) | 58.55(+138.5%) | 112.66(+92.4%) | 118.42 |
| Profit Before Interest | 190.36 | 275.67(+44.8%) | 365.39(+32.5%) | 502.75(+37.6%) | 697.71(+38.8%) | 910.65 |
| Interest Expense | 7.68 | 7.15(-6.9%) | 6.05(-15.4%) | 61.08(+909.6%) | 91.43(+49.7%) | 78.59 |
| Profit Before Tax | 182.68 | 268.52(+47.0%) | 359.34(+33.8%) | 441.67(+22.9%) | 606.28(+37.3%) | 832.06 |
| Tax Expense | 17.28 | 35.55(+105.7%) | 54.11(+52.2%) | 71.18(+31.5%) | 120.23(+68.9%) | 168.67 |
| Net Income | 165.4 | 232.97(+40.9%) | 305.23(+31.0%) | 370.49(+21.4%) | 486.05(+31.2%) | 663.39 |
| Earnings Per Share | 10.135 | 13.849(+36.6%) | 17.848(+28.9%) | 21.681(+21.5%) | 28.386(+30.9%) | 38.665 |
| Dividends Per Share | 1.2 | 54.5(+4441.7%) | 10(-81.7%) | 0(-100.0%) | 0 | 0 |
| Payout Ratio | 0.118 | 3.935(+3223.9%) | 0.56(-85.8%) | 0(-100.0%) | 0 | 0 |